Followers | 471 |
Posts | 29502 |
Boards Moderated | 1 |
Alias Born | 11/12/2016 |
Wednesday, November 14, 2018 3:08:46 AM
Current Share Structure
as of November 13th
OS 515,434,930
Float 480,087,726
Restricted 35,347,204
There is at least 120 thousand dollars left to convert into shares. They convert at a 60% discount of the low close (.0008) for the past 10 days (see below).
https://ih.advfn.com/stock-market/USOTC/cardiff-lexington-corporation-CDIX/historical
(Originally it was 240k plus interest)
(Two notes, 100k and 140k)
No new notes are available till mid Feb after the current conversions are absorbed into the market.
The current conversion rate on the low of .0008 minus discount of 60% is .00032
120k / .00032 is 375 million conversion shares
The above calculations assumes .0008 holds as the low for the remaining conversions.
conversion rates get reset every time a new low is reached or if the pps stays above the previous low for 10 trading days.
New calculations on remaining debt need to done at each reset
Normally it goes down not up
But anything is possible
This is why its called “Death Spiral Financing”
https://en.m.wikipedia.org/wiki/Death_spiral_financing
Once the market absorbs these new shares I still think this can see .005+ sometime in mid to late Jan/2019 with an OS around 1 billion and no new conversions till mid February, and a much improved Q3.
Recent CDIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:50:17 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 11/29/2023 03:18:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/16/2023 09:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 07:06:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 07:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:56:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 05:25:09 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 08:51:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 09:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 08:04:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM